ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $230,868 | +13.2% | 5,692 | -3.1% | 0.13% | +10.5% |
| Q2 2022 | $204,000 | -24.4% | 5,872 | 0.0% | 0.11% | -7.3% |
| Q1 2022 | $270,000 | -30.6% | 5,872 | 0.0% | 0.12% | -19.1% |
| Q4 2021 | $389,000 | -10.8% | 5,872 | -15.9% | 0.15% | -15.6% |
| Q3 2021 | $436,000 | -25.1% | 6,984 | -0.6% | 0.18% | -27.4% |
| Q2 2021 | $582,000 | +17.3% | 7,024 | -4.7% | 0.25% | +17.0% |
| Q1 2021 | $496,000 | -11.9% | 7,373 | 0.0% | 0.21% | -20.0% |
| Q4 2020 | $563,000 | +77.6% | 7,373 | 0.0% | 0.26% | +43.2% |
| Q3 2020 | $317,000 | +0.6% | 7,373 | +1.0% | 0.18% | -3.6% |
| Q2 2020 | $315,000 | +50.0% | 7,303 | -2.4% | 0.19% | +11.6% |
| Q1 2020 | $210,000 | – | 7,482 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |